Ralf Wunderlich - AptarGroup Independent Director
| ATR Stock | USD 175.50 0.20 0.11% |
Director
Mr. Ralf Klaus Wunderlich is an Independent Director of the Company. Mr. Wunderlich is an advisor and operating partner to several private equity companies. He was a member of Amcor Limited Global Executive Team and was President of the business group Amcor Flexibles Asia Pacific from 2010 to 2016. Mr. Wunderlich was a director of AMVIG Holdings Limited from 2010 to 2015 since 2009.
| Age | 55 |
| Tenure | 15 years |
| Address | 265 Exchange Drive, Crystal Lake, IL, United States, 60014 |
| Phone | 815 477 0424 |
| Web | https://www.aptar.com |
AptarGroup Management Efficiency
The company has Return on Asset of 0.0701 % which means that on every $100 spent on assets, it made $0.0701 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1408 %, implying that it generated $0.1408 on every 100 dollars invested. AptarGroup's management efficiency ratios could be used to measure how well AptarGroup manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AptarGroup's Return On Capital Employed is relatively stable compared to the past year. As of 11/13/2024, Return On Assets is likely to grow to 0.08, while Return On Tangible Assets are likely to drop 0.06. At this time, AptarGroup's Total Assets are relatively stable compared to the past year. As of 11/13/2024, Non Current Assets Total is likely to grow to about 3 B, while Total Current Assets are likely to drop slightly above 919.2 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Claire Pomeroy | Haemonetics | 65 | |
| Paula Johnson | West Pharmaceutical Services | 59 | |
| Douglas Michels | West Pharmaceutical Services | 63 | |
| William Kozy | The Cooper Companies, | 69 | |
| Colleen Jay | The Cooper Companies, | 58 | |
| Mark Kroll | Haemonetics | 67 | |
| Thomas Hofmann | West Pharmaceutical Services | 68 | |
| Mark Buthman | West Pharmaceutical Services | 60 | |
| John Heinmiller | Teleflex Incorporated | 66 | |
| Maria Rivas | The Cooper Companies, | 57 | |
| Candace Duncan | Teleflex Incorporated | 67 | |
| Robert Friel | West Pharmaceutical Services | 65 | |
| Andrew Krakauer | Teleflex Incorporated | 66 | |
| Charles Dockendorff | Haemonetics | 66 | |
| Richard Packer | Teleflex Incorporated | 62 | |
| Gary Petersmeyer | The Cooper Companies, | 73 | |
| Stephen Klasko | Teleflex Incorporated | 67 | |
| Deborah Tanner | West Pharmaceutical Services | 57 | |
| Michael Coyle | Haemonetics | 58 | |
| George Babich | Teleflex Incorporated | 69 | |
| Stuart Randle | Teleflex Incorporated | 61 | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0701 |
AptarGroup Leadership Team
Elected by the shareholders, the AptarGroup's board of directors comprises two types of representatives: AptarGroup inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AptarGroup. The board's role is to monitor AptarGroup's management team and ensure that shareholders' interests are well served. AptarGroup's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AptarGroup's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shiela Vinczeller, Chief Human Resource Officer | ||
| B Owens, Independent Director | ||
| Marry Skafidas, Senior Communications | ||
| Jenwei Wu, Independent Director | ||
| Daniel Ackerman, Chief Officer | ||
| Mary Skafidas, Senior Communications | ||
| Stephan Tanda, President, Chief Executive Officer, Director | ||
| Andreas Kramvis, Independent Director | ||
| Ralf Wunderlich, Independent Director | ||
| Robert Kuhn, Chief Financial Officer, Executive Vice President, Secretary | ||
| Maritza Montiel, Independent Director | ||
| Marc Prieur, President - Aptar Food + Beverage | ||
| Giovanna Monnas, Independent Director | ||
| Eldon Schaffer, Executive Vice President - Strategic Projects and Commercial Excellence | ||
| Hedi Tlili, President Beverage | ||
| Isabel MareySemper, Independent Director | ||
| Candace Matthews, Independent Director | ||
| George Fotiades, Independent Non-Executive Chairman of the Board | ||
| Gael Touya, President Aptar Food and Beverage | ||
| Heidi Tlili, President - Aptar Food + Beverage | ||
| Xiangwei Gong, President - Aptar Asia | ||
| Jesse Wu, Independent Director | ||
| Joanne Smith, Independent Director | ||
| Kimberly Chainey, Executive Vice President Global General Counsel, Secretary | ||
| Matthew DellaMaria, VP Communications |
AptarGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AptarGroup a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0701 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 12.5 B | |||
| Shares Outstanding | 66.54 M | |||
| Shares Owned By Insiders | 0.56 % | |||
| Shares Owned By Institutions | 93.58 % | |||
| Number Of Shares Shorted | 520.76 K | |||
| Price To Earning | 28.95 X |
Pair Trading with AptarGroup
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AptarGroup position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will appreciate offsetting losses from the drop in the long position's value.Moving against AptarGroup Stock
| 0.87 | EVFM | Evofem Biosciences | PairCorr |
| 0.84 | NEPH | Nephros | PairCorr |
| 0.82 | ESMC | Escalon Medical Corp | PairCorr |
| 0.8 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.79 | DYNT | Dynatronics | PairCorr |
The ability to find closely correlated positions to AptarGroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AptarGroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AptarGroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AptarGroup to buy it.
The correlation of AptarGroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AptarGroup moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AptarGroup moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AptarGroup can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for AptarGroup Stock Analysis
When running AptarGroup's price analysis, check to measure AptarGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptarGroup is operating at the current time. Most of AptarGroup's value examination focuses on studying past and present price action to predict the probability of AptarGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptarGroup's price. Additionally, you may evaluate how the addition of AptarGroup to your portfolios can decrease your overall portfolio volatility.